Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men.

MLA

Reginster, Jean-Yves, et al. “Recommendations for an Update of the Current (2001) Regulatory Requirements for Registration of Drugs to Be Used in the Treatment of Osteoporosis in Postmenopausal Women and in Men.” Osteoporosis International : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 17, no. 1, Jan. 2006, pp. 1–7. EBSCOhost, https://doi.org/10.1007/s00198-005-1984-3.

APA

Reginster, J.-Y., Abadie, E., Delmas, P., Rizzoli, R., Dere, W., der Auwera, P., Avouac, B., Brandi, M.-L., Daifotis, A., Diez-Perez, A., Calvo, G., Johnell, O., Kaufman, J.-M., Kreutz, G., Laslop, A., Lekkerkerker, F., Mitlak, B., Nilsson, P., Orloff, J., … Flamion, B. (2006). Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in men. Osteoporosis International : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 17(1), 1–7. https://doi.org/10.1007/s00198-005-1984-3

Chicago

Reginster, Jean-Yves, Eric Abadie, Pierre Delmas, René Rizzoli, Willard Dere, Philippevan der Auwera, Bernard Avouac, et al. 2006. “Recommendations for an Update of the Current (2001) Regulatory Requirements for Registration of Drugs to Be Used in the Treatment of Osteoporosis in Postmenopausal Women and in Men.” Osteoporosis International : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 17 (1): 1–7. doi:10.1007/s00198-005-1984-3.